What we do
ProteinExpress focuses its business on exploring and validating seeds of novel drugs as a genome-based drug discovery company. Our business is based on recombinant DNA technology for effective protein production.

Genome-based Drug Seed Development Projects
Genome-based Drug Discovery Project
  - Targeting genes for drug discovery
  - Identifying target proteins by proteomics
  - Validating drug seeds
KIAA Project
  - Producing antibodies as a proteome analysis tool
- Proteomics with the utilization of antibodies
Other Business Activities
  Development of protein-based pharmaceuticals
Protein expression & production service